CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
116331-58-9 | Angiotensin II,1-de-L-aspartic acid-2-(N-methylglycine)-5-L-isoleucine-8-L-isoleucine- (9CI); [SAR1,Ile7]-ANGIOTENSIN III ACETATE SALT; SAR-VAL-TYR-Ile-His-Pro-Ile ACETATE SALT; (SAR1,Ile7)-ANGIOTENSIN III; [sar1, Ile7]-angiotensin iii acetate hydrate; sar-val-tyr-Ile-His-Pro-Ile; angiotensin III, Sar(1)-Ile(7)-; [Sar1, Ile7]-Angiotensin III hydrate acetate salt | ![]() | C42H65N9O11 | 詳情 | 供應商 | |
37827-06-8 | L-Isoleucine,N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-Histidyl-L-Prolyl-; AngiotensinII, 1-(N-methylglycine)-5-L-isoleucine-8-L-isoleucine-; Angiotensin IIIinhibitor (human), N2-(N-methylglycyl)- (9CI); SarIlesin; [Sar1-Ile5-Ile8]-angiotensin II; [Sarcosyl1-Ile5-Ile8]-angiotensin II | ![]() | C46H73N13O10 | 詳情 | 供應商 | |
144774-75-4 | Neurokinin A (Ranaridibunda perezii) (9CI); Eledoisin,1-de(5-oxo-L-Proline)-2-L-Histidine-3-L-lysine-4-L-leucine-6-L-serine-; L-Methioninamide, L-Histidyl-L-lysyl-L-leucyl-L-a-aspartyl-L-seryl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-; [Leu3,Ile7]Neurokinin A | ![]() | C53H86N14O13S | 詳情 | 供應商 | |
1225-60-1 | 10H-Pyrido[3,2-b][1,4]benzothiazine-10-ethanamine,N,N,a-trimethyl-, hydrochloride (1:1); 10H-Pyrido[3,2-b][1,4]benzothiazine,10-[2-(dimethylamino)Propyl]-, monohydrochloride (8CI); 10H-Pyrido[3,2-b][1,4]benzothiazine-10-ethanamine, N,N,a-trimethyl-, monohydrochloride(9CI); Andantol; Andanton; Isothipendyl hydrochloride; Isothipendylmonohydrochloride; NSC 169186; NIlergex; TheruHistin | ![]() | C16H20ClN3S | 詳情 | 供應商 | |
23025-68-5 | [des-Arg1]-Angiotensin III | 3-8-Angiotensin II,5-L-isoleucine-; Alanine,3-phenyl-N-[1-[N-[N-(N-L-valyl-L-tyrosyl)-L-isoleucyl]-L-Histidyl]-L-Prolyl]-(7CI); Alanine, 3-phenyl-N-[1-[N-[N-(N-valyltyrosyl)isoleucyl]Histidyl]Prolyl]-(6CI); Angiotensin II, 1-de-L-aspartic acid-2-de-L-arginine-5-L-isoleucine-(8CI); Angiotensin IV, 3-L-isoleucine- (9CI); (3-8)-5-Isoleucine-angiotensinII; (Isoleucine5)-angiotensin II hexapeptide; 1-De-L-aspartic-2-de-L-arginine-5-L-isoleucineangiotensinII; 10: PN: WO2008138350 SEQID: 10 claimed sequence; 10: PN: WO9958140 SEQID: 3claimed Protein; 1: PN: US20080124807 PAGE: 12 claimed Protein; 1: PN:WO03011304 SEQID: 2 claimed Protein; 1: PN: WO2007024946 SEQID: 1 unclaimedsequence; 2: PN: US6762167 SEQID: 3 unclaimed sequence; 2: PN: WO0144270 SEQID:3 claimed Protein; 3: PN: WO0056345 SEQID: 3 claimed sequence; 3: PN: WO0143761SEQID: 3 claimed Protein; 3: PN: WO0155176 SEQID: 3 claimed Protein; 3: PN: WO0198325SEQID: 3 claimed Protein; 3: PN: WO02087504 SEQID: 3 claimed Protein; 43: PN:US20090227507 SEQID: 6 unclaimed Protein; 458: PN: WO0069900 SEQID: 644unclaimed sequence; 4: PN: US20030130196 SEQID: 3 claimed Protein; 5-Isoleucine-angiotensin II 3-8-hexapeptide; 534: PN: US20090175821 SEQID: 644claimed Protein; 5: PN: US20050222044 SEQID: 5 unclaimed sequence; 5: PN:US20080026409 SEQID: 2 unclaimed sequence; 5: PN: WO03072059 SEQID: 6 unclaimedsequence; 74: PN: WO2007103770 SEQID: 74 claimed sequence; Angiotensin IV; Human angiotensin IV; Human angiotensin hexapeptide(3-8); Humanangiotensin(3-8); Ile3-angiotensin IV; [Des(Asp1,Arg2)-Ile5]angiotensin II; [Des-Asp1,des-Arg2,Ile5]-angiotensin II; [Ile5]-angiotensin II (3-8) | ![]() | C40H54N8O8 | 詳情 | 供應商 |
740980-24-9 | ACV 1; ACV 1; GLY-CYS-CYS-SER-ASP-Pro-ARG-CYS-ASN-TYR-ASP-His-Pro-GLU-Ile-CYS-NH2 | ![]() | C71H103N23O25S4 | 詳情 | 供應商 | |
532932-99-3 | ARG-SER-GLY-Pro-Pro-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-His-ALA-ALA-GLY-IL | (ALA11,D-LEU15)-OREXIN B (HUMAN); ARG-SER-GLY-Pro-Pro-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-His-ALA-ALA-GLY-Ile-LEU-THR-MET-NH2; H-ARG-SER-GLY-Pro-Pro-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-His-ALA-ALA-GLY-Ile-LEU-THR-MET-NH2; [ALA11,D-LEU15]-OREXIN B; (ALA11,D-LEU15)-OREXIN B (HUMAN); H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2; M.W. 2857.28 C120H206N44O35S | ![]() | C120H206N44O35S | 詳情 | 供應商 |
64315-16-8 | 血管緊張素原 | ANGIOTENSINOGEN; H-ASP-ARG-VAL-TYR-Ile-His-Pro-PHE-His-LEU-LEU-VAL-TYR-SER-OH; ASP-ARG-VAL-TYR-Ile-His-Pro-PHE-His-LEU-LEU-VAL-TYR-SER; ANGIOTENSINOGEN FRAGMENT 1-14 PORCINE; ANGIOTENSINOGEN (1-14), PORCINE; ANGIOTENSINOGEN (1-14) (HORSE); ANGIOTENSINOGEN; PREANGIOTENSINOGEN (1-14) (HORSE); RENIN SUBSTRATE | ![]() | C85H123N21O20 | 詳情 | 供應商 |
68521-88-0 | 血管緊張素II | ASP-ARG-VAL-TYR-Ile-His-Pro-PHE ACETATE SALT; ANGIOTENSIN II ACETATE SALT; ANGIOTENSIN II HUMAN ACETATE SALT; ASP-ARG-VAL-TYR-Ile-His-Pro-PHE ACETATE SALT; HYPERTENSIN II; ANGIOTENSIN II, MASS SPEC STANDARD; ANGIOTENSIN II, HUMAN, SYNTHETIC; ANGIOTENSIN II ACETATE HUMAN; ANGIOTENSIN II-FLUORESCEIN SYNTHETIC >81 % | ![]() | C52H75N13O14 | 詳情 | 供應商 |
127060-75-7 | CGP 42112; NΑ-NICOTINOYL-TYR-(NΑ-CBZ-ARG)-LYS-His-Pro-Ile | CGP 42112; [N-ALPHA-(NICOTINOYL-L-TYROSYL)-N-EPSILON-(N-ALPHA-Z-L-ARGINYL)-L-LYSYL]-L HisTIDYL-L-ProLYL-L-ISOLEUCINE; N-ALPHA-NICOTINOYL-TYR-LYS(N-ALPHA-CBZ-ARG)-His-Pro-Ile; N-ALPHA-NICOTINOYL-TYR-(N-ALPHA-CBZ-ARG)-LYS-His-Pro-Ile-OH; NICOTINOYL-TYR-LYS(CBZ-ARG)-His-Pro-Ile; NICOTINOYL-TYR-LYS(Z-ARG)-His-Pro-Ile-OH; NIC-TYR-LYS(Z-ARG)-His-Pro-Ile; CGP 42112; CGP-42112A | ![]() | C52H69N13O11 | 詳情 | 供應商 |
170663-33-9 | ARG-ASP-HYP-CYS-CYS-TYR-His-Pro-THR-CYS-ASN-MET-SER-ASN-Pro-GLN-Ile-CYS | ALPHA-CONOTOXIN EL; ARG-ASP-HYP-CYS-CYS-TYR-His-Pro-THR-CYS-ASN-MET-SER-ASN-Pro-GLN-Ile-CYS; ARG-ASP-HYP-CYS-CYS-TYR-His-Pro-THR-CYS-ASN-MET-SER-ASN-Pro-GLN-Ile-CYS-NH2; H-ARG-ASP-HYP-CYS-CYS-TYR-His-Pro-THR-CYS-ASN-MET-SER-ASN-Pro-GLN-Ile-CYS-NH2; ALPHA-CONOTOXIN EI; ALPHA-CONOTOXIN EI, CONUS ERMINEUS; ALPHA-CONOTOXIN EL; ALPHA-CGTX EL; RDHYPCCYHPTCNMSNPQIC-NH2 | ![]() | C83H125N27O27S5 | 詳情 | 供應商 |
669050-68-4 | A-CONOTOXIN PIA; A-CONOTOXIN PIA; ARG-ASP-Pro-CYS-CYS-SER-ASN-Pro-VAL-CYS-THR-VAL-His-ASN-Pro-GLN-Ile-CYS-NH2; α-Conotoxin PIA | ![]() | C79H125N27O25S4 | 詳情 | 供應商 | |
113944-46-0 | CYS-THR-His-GLY-Ile-ARG-Pro-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU | HIV (GP120) FRAGMENT (254-274); HIV PEPTIDE GP120, 254-274; HIV ENVELOPE ProTEIN (254-274); HIV ENVELOPE ProTEIN (GP120) FRAGMENT 254-274; HIV (GP120) FRAGMENT (254-274); H-CYS-THR-His-GLY-Ile-ARG-Pro-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU-OH; GP120 (252-272); CYS-THR-His-GLY-Ile-ARG-Pro-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU; HIV ENVELOPE ProTEIN (GP120) FRAGMENT & | ![]() | C95H162N28O30S | 詳情 | 供應商 |
110200-37-8 | ASP-ARG-VAL-TYR-Ile-His-Pro-PHE-His-LEU-LEU-TYR-TYR-SER | ANGIOTENSINOGEN (1-14) (RAT); TETRADECAPEPTIDE RENIN SUBSTRATE (RAT); RENIN SUBSTRATE TETRADECAPEPTIDE, RAT; PREANGIOTENSINOGEN (1-14); PREANGIOTENSINOGEN (1-14) (RAT); H-ASP-ARG-VAL-TYR-Ile-His-Pro-PHE-His-LEU-LEU-TYR-TYR-SER-OH; ASP-ARG-VAL-TYR-Ile-His-Pro-PHE-His-LEU-LEU-TYR-TYR-SER; ANGIOTENSINOGEN (1-14) (RAT); Angiotensi | ![]() | C89H123N21O21 | 詳情 | 供應商 |
114547-31-8 | GALANIN (RAT) | GALANIN, RAT; GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2; GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-Pro-His-ALA-Ile-ASP-ASN-His-ARG-SER-PHE-SER-ASP-LYS-His-GLY-LEU-THR-NH2; H-GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-Pro-His-ALA-Ile-ASP-ASN-His-ARG-SER-PHE-SER-ASP-LYS-His-GLY-LEU-THR-NH2; GALANIN, RAT; Galanin(1-29)(rat,mouse); Galanine(1-29)【rat】; Galanine【rat】 | ![]() | C141H211N43O41 | 詳情 | 供應商 |
223460-79-5 | GLP-2 (HUMAN); PREProGLUCAGON (146-179) (HUMAN) TRIFLUOROACETATE SALT; PREProGLUCAGON (126-159) (HUMAN); PREProGLUCAGON (146-178) (HUMAN); His-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-Ile-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-Ile-ASN-TRP-LEU-Ile-GLN-THR-LYS-Ile-THR-ASP; H-His-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-Ile-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-Ile-ASN-TRP-LEU-Ile-GLN-THR-LYS-Ile-THR-ASP-ARG-OH; H-His-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-Ile-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-Ile-ASN-TRP-LEU-Ile-GLN-THR-LYS-Ile-THR-ASP-OH; HADGSFSDEMNTILDNLAARDFINWLIQTKITDR; GLP-2 | ![]() | C165H254N44O55S | 詳情 | 供應商 | |
195262-56-7 | His-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-Ile-LEU-ASP-ASN-LEU-ALA-THR-ARG-ASP-PHE-Ile-ASN-TRP- | GLP-2 (RAT); GLUCAGON-LIKE PEPTIDE 2 (RAT); GLUCAGON-LIKE PEPTIDE II RAT; GLP-2 (RAT); H-His-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-Ile-LEU-ASP-ASN-LEU-ALA-THR-ARG-ASP-PHE-Ile-ASN-TRP-LEU-Ile-GLN-THR-LYS-Ile-THR-ASP-OH; HADGSFSDEMNTILDNLATRDFINWLIQTKITD; PREProGLUCAGON (146-178) (RAT); ProGLUCAGON (126-158) (RAT); M.W. 3796.17 C166H256N44O56S | 無 | C166H256N44O56S1 | 詳情 | 供應商 |
118506-26-6 | VAL-His-PHE-PHE-LYS-ASN-Ile-VAL-THR-Pro-ARG-THR-Pro | MYELIN BASIC ProTEIN (87-99) (HUMAN, BOVINE, RAT); MYELIN BASIC ProTEIN (87-99), GUINEA PIG, HUMAN; MYELIN BASIC ProTEIN (87-99) (HUMAN, BOVINE, RAT); VAL-His-PHE-PHE-LYS-ASN-Ile-VAL-THR-Pro-ARG-THR-Pro; VHFFKNIVTPRTP; MBP (HUMAN, BOVINE, RAT); MBP (87-99) HUMAN; H-VAL-His-PHE-PHE-LYS-ASN-Ile-VAL-THR-Pro-ARG-THR-Pro-OH; H-VAL-His-PHE-PHE-LYS-ASN-Ile-VAL-THR-Pro-ARG-THR-Pro-OH (HUMAN, BOVINE, RAT) | ![]() | C74H114N20O17 | 詳情 | 供應商 |
843782-19-4 | LEU-Pro-ARG-LEU-LEU-His-THR-ASP-SER-ARG-MET-ALA-THR-Ile-ASP-PHE-Pro-LYS-LYS-ASP-Pro-THR-THR-SER-LEU- | H-LEU-Pro-ARG-LEU-LEU-His-THR-ASP-SER-ARG-MET-ALA-THR-Ile-ASP-PHE-Pro-LYS-LYS-ASP-Pro-THR-THR-SER-LE; H-LEU-Pro-ARG-LEU-LEU-His-THR-ASP-SER-ARG-MET-ALA-THR-Ile-ASP-PHE-Pro-LYS-LYS-ASP-Pro-THR-THR-SER-LEU-GLY-ARG-Pro-PHE-PHE-LEU-PHE-ARG-Pro-ARG-ASN-NH2; NEUROMEDIN S (RAT); NMS (RAT) | 無 | C193H307N57O49S | 詳情 | 供應商 |
90880-35-6 | 神經(jīng)肽-Y (人, 鼠) | NEUROPEPTIDE Y (HUMAN, RAT); NPY FREE ACID (HUMAN, RAT); NPY (HUMAN, RAT); NEUROPEPTIDE Y FREE ACID (HUMAN, RAT); NEUROPEPTIDE Y, HUMAN; NEUROPEPTIDE Y (HUMAN, RAT); TYP-Pro-SER-LYS-Pro-ASP-ASN-Pro-GLY-GLU-ASP-ALA-Pro-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-His-TYR-Ile-ASN-LEU-Ile-THR-ARG-GLN-ARG-TYR; YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY; H-TYR-Pro-SER-LYS-Pro-ASP-ASN-Pro-GLY-GLU-ASP-ALA-Pro-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-His-TYR-Ile-ASN-LEU-Ile-THR-ARG-GLN-ARG-TYR-OH | 無 | C189H285N55O57S1 | 詳情 | 供應商 |